Poor timing on the PR and it should of been followed up by a fresh new PR. The follow up PR was a few weeks old. Even with FDA a approval I do not see this making a good run up in pps. The people or following and whoever is buying BPAX are just completely incapable of letting any momo build up on the stock. Maybe that will change in a week or two. The stock seemed to have a decent up trend from .38 to .70 maybe a different group of shareholders were in it then. I'm not sure what is going on.
News 
Market Data 
Discover 
